Reversed phase HPLC determination of tamoxifen in dog plasma and its pharmacokinetics after a single oral dose administration

Quimica Nova

Volumn 31, Issue 1, 2008, Pages 47-52

  De Santana, Davi Pereira ^a   Braga, Rossana Maria Carvalho ^a   Strattmman, Ruth ^a   Albuquerque, Miracy Muniz ^a   Bedor, Danilo César Galindo ^a   Leal, Leila Bastos ^a   Da Silva, José Alexsandro ^b  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b STATE UNIVERSITY OF PARAÍBA   (Brazil)

Author keywords

Bioavailability; HPLC; Tamoxifen

Indexed keywords

EID: 40349106037     PISSN: 01004042     EISSN: 16787064     Source Type: Journal    
DOI: 10.1590/S0100-40422008000100010     Document Type: Article

References (33)

1. Chemical Abstracts Registry Data, American Chemical Society, Cassi CD-Rom, 2007.
2. Novaldex Professional Information Brochure. Astra-Zeneca, 2002, p. 16.
3. th ed., 1993, p. 1126.
4. Gleiter, C. H.; Klotz, U. J. Clin. Pharmacol. 1998, 38, 904.
5. Legha, S. S.; Carter, S. K.; Ann. Intern. Med., 1976, 84, 751.
6. Braga, R. M. C.; Dissertação de Mestrado, Universidade Federal de Pernambuco, Brasil, 2000.
7. Furr, B. J. A.; Jordan, V. C.; Pharmacol. Ther. 1984, 25, 127.
8. Fuchs, W. S.; Leary, W. P.; Arzeneim. Forsch. 1996, 46, 255.
9. Gjerde, J.; Kisanga, E. R.; Hauglid, M.; Hola, P. I.; Mellgren, G.; Lien, E. A.; J. Chromatogr., A 2005, 1082, 6.
10. Mihailescu, R.; Aboul-Enein, H. Y.; Efstatide, M. D.; Biomed. Chromatogr. 2000, 14, 180.
11. Merle, O.; Faure, N.; Guitton, J.; Burke, M. D.; Ollagnier, M.; Anal. Lett. 1998, 31, 2679.
12. Merle, O.; Guitton, J.; Burke, M. D.; Ollagnier, M.; Anal. Lett. 1998, 31, 2067.
13. Fried, K. M.; Wainer, I. W.; J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 1994, 655, 261.
14. Lee, K.; Ward, B. A.; J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2003, 791, 245.
15. Kisanga, E. R.; Haugan Moi, L. L.; Gjerde, J.; Mellgren, G.; Lien, E. A.; J. Steroid Biochem. Mol. Biol. 2005, 94, 489.
16. Lima, E. Q.; Dissertação Mestrado, Universidade Federal de Pernambuco, Brasil, 2000.
17. Sane, R. T.; Sonawane, K. K.; Kubal, M. L.; Nayak, V. G.; Indian Drugs 1986, 24, 154.
18. Lim, K. C.; Chow, L. C. L.; Yuan, Z.; Smith, L. L.; Biomed. Chromatog. 1993, 7, 311.
19. Golander, Y.; Sternson, L. A.; J. Chromatogr. 1980, 181, 41.
20. Agência Nacional de Vigilância Sanitária (ANVISA); Resolução RE no 899, de 29/05/2003.
21. International Conference on Harmonisation (ICH); Validation of Analytical Procedures: Text and Methodology, Q2 (R1), 2005.
22. Fonseca, S. G.; Silva, L. B. L.; Castro, R. F.; Santana, D. P.; Quim. Nova 2004, 27, 157.
23. Ribani, M.; Bottoli, C. B. G.; Collins, C. H.; Jardim, I. C. S. F.; Melo, L. F. C.; Quim. Nova 2004, 27, 771.
24. Abreu, L. R. P.; Ortiz, R. A. M.; J. Pharm. Sci. 2003, 6, 223.
25. United States Food and Drug Administration (US-FDA); Guidance for Industry, Bioanalytical Method Validation, 2001.
26. Green, J. M.; Anal. Chem. 1996, 68, A305.
27. nd ed., Ellis Horwood: Chichester, 1988.
28. Swartz, M. E.; Krull, I. S.; Analytical Method Development and Validation, Marcel Dekker, Inc.: New York, 1997.
29. Barros Neto, B.; Scarminio, I. S.; Bruns, R. E.; Como Fazer Experimentos, Ed. da Unicamp: Campinas-SP, 2001.
30. Crow, E. L.; Davis, F. A.; Maxfield, M. W.; Statistical Manual, Dover Publication: New York, 1960.
31. Massart, D. L.; Vanderginste, B. G. M.; Deming, S. N.; Chemometrics: a textboo, Elsevier Science B. V.: Amsterdam, 1988.
32. Farrant, T. J.; Pratical statistics for the analytical scientist. Laboratory, Laboratory of the Government Chemist by the Royal Society of Chemistry: Cambrigde, 1997.
33. Waddle, J. R.; Fine, R. L.; Case, B. C.; Trogdon, M. L.; Tyczkowsk, K.; Frazier, D.; Page, R. L.; Cancer Chemoth. Pharm. 1999, 44, 74.